DK1787649T3 - Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception - Google Patents

Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception

Info

Publication number
DK1787649T3
DK1787649T3 DK05022324T DK05022324T DK1787649T3 DK 1787649 T3 DK1787649 T3 DK 1787649T3 DK 05022324 T DK05022324 T DK 05022324T DK 05022324 T DK05022324 T DK 05022324T DK 1787649 T3 DK1787649 T3 DK 1787649T3
Authority
DK
Denmark
Prior art keywords
oral
estradiovalerate
dienogest
combination
unit
Prior art date
Application number
DK05022324T
Other languages
English (en)
Inventor
Susan Zeun
Pol Boudes
Jan Endrikat
Angelo Secci
Holger Zimmermann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1787649(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1787649T3 publication Critical patent/DK1787649T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK05022324T 2005-10-13 2005-10-13 Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception DK1787649T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05022324A EP1787649B1 (de) 2005-10-13 2005-10-13 Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption

Publications (1)

Publication Number Publication Date
DK1787649T3 true DK1787649T3 (da) 2009-06-02

Family

ID=35811580

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05022324T DK1787649T3 (da) 2005-10-13 2005-10-13 Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception
DK06806225.6T DK1933843T3 (da) 2005-10-13 2006-10-12 Anvendelse af østradiolvalerat eller østradiol kombineret med dienogest til oral terapi af dysfunktionel livmoderblødning i forening med oral prævention

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06806225.6T DK1933843T3 (da) 2005-10-13 2006-10-12 Anvendelse af østradiolvalerat eller østradiol kombineret med dienogest til oral terapi af dysfunktionel livmoderblødning i forening med oral prævention

Country Status (22)

Country Link
EP (2) EP1787649B1 (da)
JP (2) JP5735200B2 (da)
KR (2) KR20080065651A (da)
CN (1) CN101312733A (da)
AR (1) AR056694A1 (da)
AT (2) ATE424828T1 (da)
CA (1) CA2623024C (da)
CL (1) CL2011000283A1 (da)
CY (2) CY1110321T1 (da)
DE (2) DE502005006837D1 (da)
DK (2) DK1787649T3 (da)
DO (1) DOP2006000221A (da)
ES (2) ES2322479T3 (da)
HR (1) HRP20090256T1 (da)
ME (1) ME01056B (da)
PE (2) PE20100090A1 (da)
PL (2) PL1787649T3 (da)
PT (2) PT1787649E (da)
SI (2) SI1787649T1 (da)
TW (2) TWI328453B (da)
UY (1) UY29861A1 (da)
WO (1) WO2007042296A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ES2322479T3 (es) * 2005-10-13 2009-06-22 Bayer Schering Pharma Aktiengesellschaft Utilizacion de valerato de estradiol en combinacion con dienogest para la terapia por via oral de la hemorragia uterina disfuncional, en union con una contracepcion oral.
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DK0921804T3 (da) * 1996-07-26 2003-11-24 Wyeth Corp Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ES2322479T3 (es) * 2005-10-13 2009-06-22 Bayer Schering Pharma Aktiengesellschaft Utilizacion de valerato de estradiol en combinacion con dienogest para la terapia por via oral de la hemorragia uterina disfuncional, en union con una contracepcion oral.

Also Published As

Publication number Publication date
SI1933843T1 (sl) 2011-06-30
CA2623024C (en) 2012-03-06
SI1787649T1 (sl) 2009-08-31
DOP2006000221A (es) 2007-08-31
CY1110321T1 (el) 2015-01-14
TW200829255A (en) 2008-07-16
PL1787649T3 (pl) 2009-08-31
KR20080065651A (ko) 2008-07-14
DK1933843T3 (da) 2011-04-18
KR101218872B1 (ko) 2013-01-07
ATE497387T1 (de) 2011-02-15
EP1787649A1 (de) 2007-05-23
ES2360302T3 (es) 2011-06-02
ATE424828T1 (de) 2009-03-15
PL1933843T3 (pl) 2011-06-30
CA2623024A1 (en) 2007-04-19
EP1933843A1 (de) 2008-06-25
CY1111406T1 (el) 2015-08-05
PE20100090A1 (es) 2010-03-12
TW200731977A (en) 2007-09-01
CL2011000283A1 (es) 2011-07-08
ES2322479T3 (es) 2009-06-22
PT1787649E (pt) 2009-05-08
KR20100082389A (ko) 2010-07-16
HRP20090256T1 (en) 2009-06-30
CN101312733A (zh) 2008-11-26
UY29861A1 (es) 2007-05-31
WO2007042296A1 (de) 2007-04-19
TWI328453B (en) 2010-08-11
JP2013047269A (ja) 2013-03-07
DE502005006837D1 (de) 2009-04-23
EP1787649B1 (de) 2009-03-11
DE502006008853D1 (de) 2011-03-17
JP2009511526A (ja) 2009-03-19
PE20070555A1 (es) 2007-07-12
JP5735200B2 (ja) 2015-06-17
PT1933843E (pt) 2011-04-29
AR056694A1 (es) 2007-10-17
ME01056B (me) 2012-10-20
EP1933843B1 (de) 2011-02-02

Similar Documents

Publication Publication Date Title
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK1827412T3 (da) Sammensætninger til anvendelse i kirurgi
DK1984322T3 (da) Benzamid- og heteroarenderivater
DK2049525T3 (da) N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
ATE432056T1 (de) Zervikale zwischenwirbelprothese
DE602005002413D1 (de) Wegwerfhöschen
ATE509596T1 (de) Zervikale zwischenwirbelprothesen
BRPI0815204A2 (pt) Dispositivo de administração fecal e utilização do dispositivo
EP2114322A4 (en) ORTHOPEDIC CLAMPS AND COMPONENTS FOR USE THEREIN
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
IL196113A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
FR2874166B1 (fr) Agrafe chirurgicale
SI2254869T1 (sl) Novi 1-benzil-3-hidroksimetilindazolni derivati in njihova uporaba pri zdravljenju bolezni, ki temeljijo na ekspresiji CX3CR1 in p40
DK2262778T5 (da) 1-benzyl-3-hydroxymethylindazolderivativer og brug deraf i behandling af sygdomme baseret på ekspression af mcp-1, cx3cr1 og p40
DK2918288T3 (da) Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi
DK2012745T3 (da) Mundplejesammensætning med siliconekomposit
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
BRPI0717212A2 (pt) fralda descartÁvel tipo calÇa
DK1858481T3 (da) Ophthalmologiske sammensætninger og anvendelse deraf
DE602005004879D1 (de) Zahnmedizinischer absorbierender Verband
DE602006000612D1 (de) Beidseitig tragbare Orthese
DK1787649T3 (da) Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception
DK1940840T3 (da) 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf
DK2194968T3 (da) Lerbaseret, aromatiseret og terapeutisk sammensætning
DK2106401T3 (da) Derivater af pyrrolopyridin-2-carboxamider, fremstilling deraf og terapeutisk anvendelse deraf